| Code | Description | Claims | Beneficiaries | Total Paid |
| 77300 |
|
1,177 |
496 |
$753K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
2,464 |
2,266 |
$570K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
2,135 |
1,934 |
$552K |
| G0378 |
Hospital observation service, per hour |
1,401 |
717 |
$424K |
| J0475 |
Injection, baclofen, 10 mg |
746 |
728 |
$384K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,252 |
1,196 |
$331K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
4,347 |
3,856 |
$270K |
| 77334 |
|
535 |
384 |
$263K |
| 77386 |
|
294 |
28 |
$165K |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
409 |
394 |
$149K |
| 86832 |
|
544 |
508 |
$144K |
| 86833 |
|
544 |
507 |
$144K |
| 80053 |
Comprehensive metabolic panel |
14,979 |
11,430 |
$113K |
| 77301 |
|
100 |
69 |
$109K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
1,827 |
1,320 |
$98K |
| J1439 |
Injection, ferric carboxymaltose, 1 mg |
75 |
54 |
$97K |
| 83880 |
|
3,043 |
2,674 |
$96K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
17,512 |
13,219 |
$93K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,221 |
1,082 |
$88K |
| 77338 |
|
138 |
95 |
$85K |
| 70450 |
Computed tomography, head or brain; without contrast material |
922 |
866 |
$83K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,473 |
1,218 |
$74K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,498 |
1,373 |
$68K |
| CP007 |
|
1,594 |
1,285 |
$68K |
| 62370 |
|
743 |
729 |
$66K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
258 |
255 |
$60K |
| 86849 |
|
566 |
518 |
$55K |
| 71046 |
Radiologic examination, chest; 2 views |
1,865 |
1,738 |
$55K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
1,248 |
573 |
$54K |
| 71250 |
|
726 |
717 |
$53K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
455 |
414 |
$53K |
| 87497 |
|
1,090 |
799 |
$53K |
| 71045 |
Radiologic examination, chest; single view |
2,340 |
2,128 |
$51K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
371 |
358 |
$47K |
| 80197 |
|
3,477 |
2,158 |
$44K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
412 |
404 |
$43K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
395 |
353 |
$40K |
| 80050 |
General health panel |
375 |
332 |
$35K |
| 84484 |
|
2,668 |
2,219 |
$35K |
| 83735 |
|
6,700 |
4,359 |
$34K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
225 |
221 |
$34K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
6,966 |
4,853 |
$33K |
| 94010 |
|
602 |
573 |
$32K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
512 |
470 |
$30K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
266 |
233 |
$30K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
1,056 |
990 |
$28K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
5,967 |
5,230 |
$25K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,619 |
1,572 |
$25K |
| 86850 |
|
1,609 |
1,275 |
$21K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
142 |
135 |
$20K |
| 94729 |
|
524 |
512 |
$19K |
| 80061 |
Lipid panel |
2,210 |
2,141 |
$19K |
| 84100 |
|
5,179 |
3,339 |
$18K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
317 |
294 |
$18K |
| Q3014 |
Telehealth originating site facility fee |
1,742 |
1,647 |
$17K |
| 94726 |
|
125 |
122 |
$17K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
560 |
514 |
$17K |
| 87799 |
|
852 |
717 |
$16K |
| 73630 |
|
693 |
539 |
$15K |
| 86352 |
|
112 |
98 |
$13K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
1,259 |
1,170 |
$13K |
| 96415 |
|
180 |
155 |
$13K |
| 81025 |
|
1,516 |
1,324 |
$13K |
| 83690 |
|
1,986 |
1,773 |
$13K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
1,310 |
1,203 |
$12K |
| 82248 |
|
2,160 |
1,543 |
$12K |
| 85610 |
|
3,002 |
2,415 |
$12K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
190 |
154 |
$12K |
| 36415 |
Collection of venous blood by venipuncture |
13,699 |
10,878 |
$11K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,080 |
2,024 |
$11K |
| 73030 |
|
421 |
359 |
$11K |
| 83970 |
|
667 |
633 |
$11K |
| 83615 |
|
2,520 |
1,626 |
$10K |
| 87631 |
|
67 |
62 |
$10K |
| 83605 |
|
949 |
847 |
$10K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
69 |
58 |
$10K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
87 |
79 |
$10K |
| 82728 |
|
1,342 |
1,233 |
$9K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,250 |
2,155 |
$9K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
170 |
77 |
$8K |
| 87088 |
|
1,823 |
1,686 |
$8K |
| 81001 |
|
4,015 |
3,534 |
$8K |
| 85027 |
|
2,372 |
1,878 |
$7K |
| 86140 |
|
1,734 |
1,564 |
$7K |
| 84439 |
|
1,274 |
1,168 |
$6K |
| 97162 |
|
177 |
160 |
$6K |
| 64643 |
|
43 |
38 |
$6K |
| 87186 |
|
838 |
779 |
$6K |
| 87077 |
|
929 |
856 |
$6K |
| 84153 |
|
475 |
436 |
$6K |
| 96417 |
|
33 |
26 |
$5K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
1,716 |
1,030 |
$5K |
| 82550 |
|
841 |
779 |
$5K |
| 94618 |
|
54 |
53 |
$5K |
| 82784 |
|
648 |
569 |
$5K |
| 99152 |
|
209 |
194 |
$5K |
| 83550 |
|
906 |
865 |
$5K |
| 87340 |
|
647 |
597 |
$4K |
| 73610 |
|
179 |
136 |
$4K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
157 |
154 |
$4K |
| 94060 |
|
59 |
56 |
$4K |
| 64644 |
|
119 |
117 |
$4K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
41 |
40 |
$4K |
| 82607 |
|
564 |
546 |
$4K |
| 83540 |
|
989 |
938 |
$4K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,085 |
1,835 |
$4K |
| 95874 |
|
271 |
259 |
$4K |
| 85730 |
|
958 |
884 |
$4K |
| 87040 |
|
291 |
242 |
$3K |
| 93971 |
|
46 |
44 |
$3K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
15 |
13 |
$3K |
| 96367 |
|
19 |
13 |
$3K |
| 87070 |
|
555 |
458 |
$3K |
| 73562 |
|
56 |
38 |
$3K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
3,024 |
2,339 |
$3K |
| 84550 |
|
1,234 |
772 |
$3K |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
12 |
12 |
$3K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
2,619 |
1,904 |
$3K |
| 82803 |
|
101 |
88 |
$3K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
2,853 |
2,644 |
$3K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
18 |
12 |
$3K |
| 86900 |
|
1,648 |
1,316 |
$3K |
| 86901 |
|
1,646 |
1,324 |
$3K |
| 86704 |
|
291 |
278 |
$2K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
82 |
70 |
$2K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,982 |
1,587 |
$2K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
23 |
23 |
$2K |
| 82043 |
|
1,521 |
1,309 |
$2K |
| 77336 |
|
169 |
91 |
$2K |
| 36591 |
|
76 |
50 |
$2K |
| 84156 |
|
1,727 |
1,433 |
$2K |
| 81003 |
|
811 |
745 |
$2K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
1,224 |
1,146 |
$2K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
104 |
101 |
$2K |
| 82375 |
|
131 |
113 |
$2K |
| 81002 |
|
197 |
195 |
$2K |
| 82570 |
|
690 |
595 |
$2K |
| 82565 |
|
602 |
584 |
$2K |
| 86803 |
|
110 |
107 |
$2K |
| 73502 |
|
27 |
24 |
$1K |
| 99153 |
Mod sedat endo service >5yrs |
15 |
14 |
$1K |
| 73130 |
|
41 |
29 |
$1K |
| 86706 |
|
125 |
118 |
$1K |
| 73560 |
|
18 |
15 |
$1K |
| 83883 |
|
194 |
175 |
$1K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,056 |
813 |
$1K |
| A9585 |
Injection, gadobutrol, 0.1 ml |
581 |
549 |
$1K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
2,704 |
2,191 |
$1K |
| 82105 |
|
69 |
66 |
$1K |
| 80076 |
|
240 |
231 |
$1K |
| 82533 |
|
58 |
50 |
$1K |
| 84165 |
|
241 |
224 |
$914.46 |
| 88307 |
|
13 |
12 |
$892.95 |
| 85652 |
|
659 |
614 |
$835.24 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
398 |
321 |
$772.72 |
| 85045 |
|
255 |
201 |
$746.66 |
| 82024 |
|
28 |
24 |
$723.59 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
26 |
24 |
$642.62 |
| 72100 |
|
26 |
26 |
$617.45 |
| 88341 |
|
15 |
12 |
$579.96 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,524 |
1,367 |
$559.43 |
| 84480 |
|
38 |
38 |
$553.07 |
| S3620 |
Newborn metabolic screening panel, includes test kit, postage and the laboratory tests specified by the state for inclusion in this panel (e.g., galactose; hemoglobin, electrophoresis; hydroxyprogesterone, 17-d; phenylalanine (pku); and thyroxine, total) |
13 |
13 |
$550.81 |
| 87205 |
|
219 |
177 |
$453.40 |
| 88342 |
|
59 |
56 |
$443.83 |
| 76830 |
Ultrasound, transvaginal |
13 |
12 |
$391.34 |
| 96376 |
|
272 |
242 |
$351.33 |
| 84403 |
|
15 |
15 |
$308.13 |
| 84155 |
|
291 |
265 |
$287.93 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
953 |
767 |
$227.19 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
238 |
180 |
$222.91 |
| 36416 |
|
21 |
18 |
$221.27 |
| 82016 |
|
13 |
13 |
$204.30 |
| 82128 |
|
13 |
13 |
$171.85 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
34 |
27 |
$162.15 |
| J3490 |
Unclassified drugs |
124 |
106 |
$153.00 |
| 85007 |
|
161 |
107 |
$144.84 |
| 85379 |
|
15 |
15 |
$127.74 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
543 |
505 |
$122.06 |
| 86038 |
|
12 |
12 |
$108.79 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
336 |
304 |
$96.31 |
| 82962 |
|
4,189 |
3,261 |
$95.11 |
| 88240 |
|
13 |
13 |
$82.02 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
46 |
37 |
$65.40 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
334 |
298 |
$44.08 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
427 |
371 |
$33.37 |
| C1769 |
Guide wire |
454 |
425 |
$12.45 |
| J2704 |
Injection, propofol, 10 mg |
3,022 |
2,106 |
$8.18 |
| 83521 |
|
16 |
14 |
$5.17 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
3,207 |
2,587 |
$0.00 |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
24 |
24 |
$0.00 |
| J0688 |
Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg |
126 |
100 |
$0.00 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
35 |
32 |
$0.00 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
28 |
28 |
$0.00 |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
13 |
12 |
$0.00 |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
16 |
13 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
16 |
12 |
$0.00 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
187 |
159 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
101 |
89 |
$0.00 |
| A9698 |
Non-radioactive contrast imaging material, not otherwise classified, per study |
65 |
65 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
58 |
58 |
$0.00 |